|
|
 |
 |
| |
| |
| Deadilne for Submission: January 15, 2008 |
| |
Topics for oral and poster presentations:
• Cardiology
• Diagnosis
• Epidemiology
• Etiology / Pathogenesis
• Imaging
• Immunology
• Genetics
• Long-term Sequalae
• Pathology / Animal Models
• Treatment |
|
| |
| |
| |
| Guidelines for abstract submission |
 |
Sample Abstract
SURVEILLANCE OF KAWASAKI DISEASE IN TAIWAN AND REVIEW OF THE LITERATURE
Lue HC, Phillips S, Chen MR, Wang JK, Wu MH.
Department of Pediatrics, Min-Sheng General Hospital, Taoyuan, Taiwan.
BACKGROUND: Kawasaki disease affects mainly children younger than five years, leading to coronary
artery lesions, even to life-threatening myocardial infarctions. Since 1976, Kawasaki disease has
occurred in thousands of children in Taiwan; some of them died.
METHODS: Questionnaire forms for the survey of epidemiological features of Kawasaki disease were
designed and sent to the hospitals of 100 or more beds in Taiwan, in 1987, 1992, 1994, and 2001,
for retrospective reviews of their patients with Kawasaki disease encountered during 1976-2000.
A school-based mass survey, on the prevalence of children with history of Kawasaki disease was
conducted every year from 1990 to 2000.
RESULTS: Since 1976, the number of Kawasaki disease patients increased, totaling to 8,267 patients
in 2000. The ratio of the incidence increased by 1.15 times annually (Poisson regression), reaching
the highest incidence of 54.9 per 100,000 children <5 years of age in 1998. Of them, 85.1% were
under 5 years of age. The male-to-female ratio was 1.6. Coronary artery lesions were noted during
acute, subacute and convalescent stages in 25.8% of the patients. The fatality rate decreased from
0.4% to 0.06%. There was no student with history of Kawasaki disease among students surveyed
in 1990. Subsequent school surveys showed the prevalence was 24.6 in 1991, 74.6 in 1996, then
reached to 103.9 per 100,000 school children in 2000, with an annual increase of 1.24 times (Poisson
regression).
CONCLUSIONS: In Taiwan, Kawasaki disease, first diagnosed in 1976, continued to occur with
several outbreaks reaching to a peak incidence of 54.9 per 100,000 population less than 5 years of
age in 1998. Epidemiological features of Kawasaki disease in Taiwan were similar to the Japanese |
|
|
| |
Please follow the “Rules for submitting abstracts”, and submit your abstract online or
via email to the Conference Secretariat at the address below, no later than January 10, 2008.
Conference Secretariat
General Innovation Service (GIS)
2F, No. 316, Wen-Chang St., Taipei 110, Taiwan
Tel: +886-2-8780-5688
Fax:+886-2-8789-3602
E-mail: kawasaki2008@convention.com.tw
On-line abstract submission
On-line abstract submission will be available from July 1, 2007.
Oral presentations
The authors of selected abstracts will be allowed 10-15 minutes for oral presentation followed by 5
minutes of discussion.
Poster presentations
The dimensions for poster presentation are 90 cm (width) by 100 cm (height). The Organizing
Committee will provide mounting with code on the upper-left corner. Posters will be discussed at
the poster site by participants and the author during poster sessions.
Acceptance
The Scientific Program Committee will make final decisions on the acceptance of abstracts.
The Committee also reserves the right to make decisions on oral or poster presentations. The
acceptance of the abstract will then be informed by Conference Secretariat via e-mail. |
| |
| |
| Rules for submitting abstracts |
| Style |
| » |
Spacing: Abstracts must be typed in SINGLE-SPACED and must be contained within the border
containing a maximum of 400 words. |
| » |
Type size and face: To ensure legibility of the abstract is reduced for printing, a minimum type size
of 10 points must be used. Do not use typefaces that resemble script. |
|
| |
| Layout |
| » |
Title: The title should be in BOLDFACE & CAPITAL and extended no more than two lines. |
| » |
Name(s)/ Institution: List the authors, institute(s) where the work originated, city and country.
The person presenting the paper should have his/ her name UNDERLINED. Omit degrees, titles,
institutional appointments, street addresses, and post/ zip codes. |
| » |
Text:The text should be arranged according to the following headings in CAPITAL:
BACKGOUND ・METHODS ・RESULTS ・CONCLUSIONS |
|
| |
| Others |
| » |
Leave lines between sections and do not indent headings. |
| » |
Only standard abbreviations may be used without definition. |
| » |
Figures, graphs, and non-standard symbols must be in black ink and legible after reduction for printing. |
| » |
Use generic drug names only. |
| » |
Do not begin sentences with numerals. |
|
| |
| |
| |
| |
| |
| |
| |
| - TOP - |
|
|
|
|
